< Back

November/December 2003, Vol.5 No.6
FDA's fast track initiative cut total drug development time by 3 years
View summary    Purchase single issue

September/October 2003, Vol.5 No.5
Switching drugs from prescription to OTC status on rise in U.S. and EU
View summary    Purchase single issue

July/August 2003, Vol.5 No.4
CROs provide gateway to worldwide clinical trial recruitment efforts
View summary    Purchase single issue

May/June 2003, Vol.5 No.3
Post-approval R&D raises total drug development costs to $897 million
View summary    Purchase single issue

March/April 2003, Vol.5 No.2
Biopharmaceutical product approval times dropped 21% since the 1980s
View summary    Purchase single issue

January/February 2003, Vol. 5 No. 1
Increased pressure on drug industry is leading to greater focus on Japan
View summary    Purchase single issue